In the ATTAIN-1 trial, people taking the highest investigational dose achieved (6): 12.4% average body weight loss over 72 weeks 55% lost at least 10% of their starting weight 18% lost at least 20% of their starting weight These results were seen at a 36mg investigational dose, higher than the 17.2mg maximum approved in the US (1)
Regardless of the type, elevated blood sugar levels can lead to damage in various systems and organs of the body, resulting in complications such as cardiovascular diseases, neuropathy, kidney diseases, retinopathy, and foot complications
Cozza G, Rossetto M, Bosello-Travain V, Maiorino M, Roveri A, Toppo S, et al
Sanibel Island, Florida: Ralph Curtis Books
These visits allow for ongoing monitoring of the patients progress, adjustment of dosages, and addressing any concerns